# A Randomized, Double Blind, Placebo Controlled Study of Etanercept in Children With Kawasaki Disease

> **NCT00841789** · PHASE2 · COMPLETED · sponsor: **Michael Portman** · enrollment: 205 (actual)

## Conditions studied

- Mucocutaneous Lymph Node Syndrome
- Kawasaki Disease

## Interventions

- **DRUG:** Etanercept
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00841789
- **Lead sponsor:** Michael Portman
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-03
- **Primary completion:** 2018-01
- **Final completion:** 2018-08-30
- **Target enrollment:** 205 (ACTUAL)
- **Last updated:** 2023-05-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00841789

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00841789, "A Randomized, Double Blind, Placebo Controlled Study of Etanercept in Children With Kawasaki Disease". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00841789. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*